The 2.0 A resolution crystal structure of prostaglandin H2 synthase-1:: Structural insights into an unusual peroxidase

被引:95
作者
Gupta, K
Selinsky, BS
Kaub, CJ
Katz, AK
Loll, PJ
机构
[1] Drexel Univ, Coll Med, Dept Biochem, Philadelphia, PA 19102 USA
[2] Univ Penn, Grad Grp Pharmacol Sci, Philadelphia, PA 19104 USA
[3] Villanova Univ, Dept Chem, Villanova, PA 19085 USA
关键词
cyclooxygenase; non-steroidal anti-inflammatory drug; peroxidase; prostaglandin synthase; membrane binding domain;
D O I
10.1016/j.jmb.2003.10.073
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostaglandin H-2 synthase (EC 1.14.99.1) is an integral membrane enzyme containing a cyclooxygenase site, which is the target for the non-steroidal anti-inflammatory drugs, and a spatially distinct peroxidase site. Previous crystallographic studies of this clinically important drug target have been hindered by low resolution. We present here the 2.0 Angstrom resolution X-ray crystal structure of ovine prostaglandin H-2 synthase-1 in complex with alpha-methyl-4-biphenylacetic-methyl-4-biphenylacetic acid, a defluorinated analog of the non- steroidal anti-inflammatory drug flurbiprofen. Detergent molecules are seen to bind to the proteins membrane-binding domain, and their positions suggest the depth to which this domain is likely to penetrate into the lipid bilayer. The relation of the enzyme's proximal heme ligand His388 to the heme iron is atypical for a peroxidase; the iron-histidine bond is unusually long and a substantial tilt angle is observed between the heme and imidazole planes. A molecule of glycerol, used as a cryoprotectant during diffraction experiments, is seen to bind in the peroxidase site, offering the first view of any ligand in this active site. Insights gained from glycerol binding may prove useful in the design of a peroxidase-specific ligand. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:503 / 518
页数:16
相关论文
共 95 条
[71]  
Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO
[72]  
2-8
[73]   Peroxidase activity in prostaglandin endoperoxide H synthase-1 occurs with a neutral histidine proximal heme ligand [J].
Seibold, SA ;
Cerda, JF ;
Mulichak, AM ;
Song, IS ;
Garavito, RM ;
Arakawa, T ;
Smith, WL ;
Babcock, GT .
BIOCHEMISTRY, 2000, 39 (22) :6616-6624
[74]   Histidine 386 and its role in cyclooxygenase and peroxidase catalysis by prostaglandin-endoperoxide H synthases [J].
Seibold, SA ;
Ball, T ;
Hsi, LC ;
Mills, DA ;
Abeysinghe, RD ;
Micielli, R ;
Rieke, CJ ;
Cukier, RI ;
Smith, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) :46163-46170
[75]   Structural analysis of NSAID binding by prostaglandin H2 synthase:: Time-dependent and time-independent inhibitors elicit identical enzyme conformations [J].
Selinsky, BS ;
Gupta, K ;
Sharkey, CT ;
Loll, PJ .
BIOCHEMISTRY, 2001, 40 (17) :5172-5180
[76]  
SHIMOKAWA T, 1991, J BIOL CHEM, V266, P6168
[77]  
SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073
[78]   NEW METHODS AND REAGENTS IN ORGANIC-SYNTHESIS .2. FACILE CONVERSION OF ALKYL ARYL KETONES TO ALPHA-ARYLALKANOIC ACIDS USING DIPHENYL PHOSPHORIZIDATE - ITS APPLICATION TO A NEW SYNTHESIS OF IBUPROFEN AND NAPROXEN, NON-STEROIDAL ANTI-INFLAMMATORY AGENT [J].
SHIOIRI, T ;
KAWAI, N .
JOURNAL OF ORGANIC CHEMISTRY, 1978, 43 (14) :2936-2938
[79]   BIOACTIVATION OF XENOBIOTICS BY PROSTAGLANDIN-H-SYNTHASE [J].
SMITH, BJ ;
CURTIS, JF ;
ELING, TE .
CHEMICO-BIOLOGICAL INTERACTIONS, 1991, 79 (03) :245-264
[80]   The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action [J].
Smith, ML ;
Hawcroft, G ;
Hull, MA .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (05) :664-674